Observational Study
 
2019 Jan 2;14(1):e0209353.
 doi: 10.1371/journal.pone.0209353. eCollection 2019.

Safety, Health Improvement and Well-Being During a 4 to 21-day Fasting Period in an Observational Study Including 1422 Subjects

Affiliations 
Free PMC article

Abstract

Only few studies document longer periods of fasting in large cohorts including non-obese participants. The aim of this study was to document prospectively the safety and any changes in basic health and well-being indicators during Buchinger periodic fasting within a specialised clinic. In a one-year observational study 1422 subjects participated in a fasting program consisting of fasting periods of between 4 and 21 days. Subjects were grouped in fasting period lengths of 5, 10, 15 and 20±2 days. The participants fasted according to the Buchinger guidelines with a daily caloric intake of 200-250 kcal accompanied by a moderate-intensity lifestyle program. Clinical parameters as well as adverse effects and well-being were documented daily. Blood examinations before and at the end of the fasting period complemented the pre-post analysis using mixed-effects linear models. Significant reductions in weight, abdominal circumference and blood pressure were observed in the whole group (each p<0.001). A beneficial modulating effect of fasting on blood lipids, glucoregulation and further general health-related blood parameters was shown. In all groups, fasting led to a decrease in blood glucose levels to low norm range and to an increase in ketone bodies levels (each p<0.001), documenting the metabolic switch. An increase in physical and emotional well-being (each p<0.001) and an absence of hunger feeling in 93.2% of the subjects supported the feasibility of prolonged fasting. Among the 404 subjects with pre-existing health-complaints, 341 (84.4%) reported an improvement. Adverse effects were reported in less than 1% of the participants. The results from 1422 subjects showed for the first time that Buchinger periodic fasting lasting from 4 to 21 days is safe and well tolerated. It led to enhancement of emotional and physical well-being and improvements in relevant cardiovascular and general risk factors, as well as subjective health complaints.

Conflict of interest statement

FWT is member of the Directory Board of the Buchinger Wilhelmi Clinic (BWC), where the study was performed. As managing director of Amplius GmbH, FWT executes the scientific leadership at BWC. Amplius GmbH is a company that conceives, coordinates and develops fasting research on behalf of BWC. FG is currently employed, and SD was formerly employed, at BWC. AM is a consultant at BWC and receives financial compensation for this role from Amplius GmbH. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1
 
Fig 2
 
Fig 3
 
Fig 4
 
Fig 5
 
Fig 6

Similar articles

 See all similar articles

Cited by 11 articles

 See all “Cited by” articles

References

    1. Mattson MP, Longo VD, Harvie M. Impact of intermittent fasting on health and disease processes. Ageing research reviews. 2017;39:46–58. 10.1016/j.arr.2016.10.005 – DOI – PMC – PubMed
    1. Mattson MP, Moehl K, Ghena N, Schmaedick M, Cheng A. Intermittent metabolic switching, neuroplasticity and brain health. Nature Reviews Neuroscience. 2018. – PMC – PubMed
    1. Yamada Y, Kemnitz JW, Weindruch R, Anderson RM, Schoeller DA, Colman RJ. Caloric Restriction and Healthy Life Span: Frail Phenotype of Nonhuman Primates in the Wisconsin National Primate Research Center Caloric Restriction Study. The Journals of Gerontology: Series A. 2018;73(3):273–8. 10.1093/gerona/glx059 – DOI – PMC – PubMed
    1. Brandhorst S, Choi IY, Wei M, Cheng CW, Sedrakyan S, Navarrete G, et al. A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell metabolism. 2015;22(1):86–99. 10.1016/j.cmet.2015.05.012 – DOI – PMC – PubMed
    1. Longo VD, Mattson MP. Fasting: molecular mechanisms and clinical applications. Cell metabolism. 2014;19(2):181–92. 10.1016/j.cmet.2013.12.008 – DOI – PMC – PubMed
 
 

Grant support

 
The study was financed by Amplius GmbH, Überlingen, Germany. This company has the task to develop a research department for the Buchinger Wilhelmi Clinics Überlingen and Marbella who are the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.

LinkOut – more resources

Please follow and like us: